$VXRT Next week's catalyst for VXRT starts with a report on the data from universal Influenza vaccine collaboration with Johnson & Johnson's (NYSE: JNJ) Janssen unit. I hope this would be an excellent report to fuel VXRT's momentum.
  • 9
9 Likes